IBCL-1332: Phase 3 Results From the EPCORE FL-1 Trial of Epcoritamab With Lenalidomide and Rituximab vs Lenalidomide and Rituximab for Relapsed or Refractory Follicular Lymphoma
Bradley D. Hunter, Lorenzo Falchi, Marcel Nijland, Huiqiang Huang et autres